A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

  • Cell Res. 2017 Mar;27(3):440-443. doi: 10.1038/cr.2017.16.
Chao Jiang  1 ,  Miao Mei  1 ,  Bin Li  2 ,  Xiurui Zhu  3 ,  Wenhong Zu  1 ,  Yujie Tian  1 ,  Qiannan Wang  1 ,  Yong Guo  3 ,  Yizhou Dong  2 ,  Xu Tan  1
Affiliations
  • 1. School of Pharmaceutical Sciences, Center for Infectious Disease Research, School of Medicine, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China.
  • 2. Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA.
  • 3. Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, China.
PMID: 28117345 DOI: 10.1038/cr.2017.16
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-148049
    TT3
    98.0%, Lipid-like Compound
    target: Liposome
    Research Areas: Others